Organized in collaboration with the SQN

Friday, October 4th, and Saturday, October 5th, 2024

Démarches Visant à enrayer l’Émergence des conséquences Néfastes de l’Insuffisance Rénale

Printable Version Click Here

---

Skills development in the CanMEDS roles targeted by this activity:

• Medical Expert
• Communicator
• Collaborator
• Leader
• Scholar
• Professional

 

Accreditation

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and a Recognized Professional Development Activity (Category A) as defined by the Collège des médecins du Québec. This activity was approved by the direction de Développement professionnel continu (DDPC) of the Fédération des médecins spécialistes du Québec.  

You may claim a maximum of 8.5 Accredited Group Learning Activity (Section 1) / Recognized Professional Development Activity (Category A) hours. Participants must claim a number of hours consistent with their attendance. 

 

GENERAL LEARNING OBJECTIVES

1. To promote, through multidisciplinarity, a comprehensive healthcare approach for clients with chronic kidney disease and for related co-morbid clinical conditions.
2. To generate optimal use of the skills of the members of the multidisciplinary teams (physicians, pharmacists, nurses, dietitians), in the healthcare process for this client group.

*** NOTE: For the 22ND ANNUAL CONFERENCE OF “FONDATION D.E.V.E.N.I.R.”, participants can register and join either the half-day session of this continuing medical education on October 4th or the half-day session on Saturday, October 5th, or opt for both half-day sessions. *** 

The specific objectives for each conference are indicated at the end of the program (see below)

SCIENTIFIC PROGRAM – DAY 1

***Note: A simultaneous translation service from English to French and from French to English will be available. You must bring your headphones and your electronic devices for accessing the translation service.

Friday, October 4, 2024

11:30-13:00	ARRIVAL OF PARTICIPANTS (Registration)	Foyer 200
	PLENARY SESSIONS	Room 201
13:00-13:15	OPENING REMARKS OVERVIEW OF SCIENTIFIC PROGRAM	Dr. Daniel Garceau Dr. Louis-Denis Poulin
Conference 1 13:15-14:15	“ARTIFICIAL INTELLIGENCE IN NEPHROLOGY: FOR NOW, OR FOR LATER?”	Dr. Wisit Cheungpasitporn
Conference 2 14:15-15:15	“AUTOIMMUNE DISEASES, VASCULITIS AND PREGNANCY; HOW TO TRANSFORM A DREAM TO REALITY!”	Prof. Angela Tincani
15:15-15:50	HEALTH BREAK	Foyer 200
Conference 3 15:50-17:55	“HIGHLIGHTS IN 2024 TO SHARE” (Lectures in French)
	15:50-16:15 : The Nurse’s / SNP’s Vision	Ms. Isabelle Vaillant
	16:15-16:40 : The Pharmacist’s Vision	Ms. Jodianne Couture
	16:40-17:05 : The Nephrologist’s Vision	Dr. Philippe Lachance
	17:05-17:30 The Nutritionist’s Vision	Ms. Roxanne Papineau
	17:30-17:55 : Question Period
18:30-19:30	COCKTAIL	Foyer 200
19:30-22:00	DINNER	Room 201

This program receives unrestricted educational grants from pharmaceutical companies Amgen Canada and Otsuka Canada without any regards to the choice of speakers, topics, choice of members of the scientific committee. We also offer our thanks to Amgen Canada as exhibitor.

SCIENTIFIC PROGRAM – DAY 2

Note: A simultaneous translation service from English to French and from French to English will be available. You must bring your headphones and your electronic devices for accessing the translation service.***

Saturday, October 5, 2024

Edit

7:00-8:00	BUFFET BREAKFAST	Foyer 200
	PLENARY SESSIONS	Room 201
8:00-8:10	OPENING REMARKS OVERVIEW OF SCIENTIFIC PROGRAM	Dr. Daniel Garceau Dr. Louis-Denis Poulin
Conference 4 8:10-9:10	“WATER AND SALT INTAKE WITH CKD; IS IT TOO MUCH OR NOT ENOUGH?” ”	Dr. Biff F. Palmer
Conference 5 9:10-10:25	“A KIDNEY GRAFT RECIPIENT; THE BEGINNING AND THE END OF THE STORY”
Part 1: 9:10-9:40	“PREEMPTIVE KIDNEY GRAFT: A USER GUIDE”	Dr. Michelle A. Josephson
Part 2: 9:40-10:10	“THE FAILING KIDNEY GRAFT; ANOTHER USER GUIDE FOR HEALTHCARE PROFESSIONALS INVOLVED IN CKD CARE”	Dr. Michelle A. Josephson
10:10-10:25	JOINT Q&A AND DISCUSSION SESSION
10:25-11:00	HEALTH BREAK	Foyer 200
Conference 6 11:00-12:25	“SHARED DECISION MAKING IN CKD; A PATIENT’S AND A CAREGIVER’S PERSPECTIVE”
Part 1: 11:00-11:30	“SHARED DECISION MAKING: WHAT IS THE LITERATURE AND RESEARCH TELLING US IN 2024?” (Lecture in French)	Dr. Patrick Archambault
Part 2: 11:30-11:55	“SHARED DECISION MAKING IN CKD; A PATIENT’S PERSPECTIVE” (Lecture in French)	Mr. Réjean Lemoine
11:55-12:25	JOINT Q&A AND DISCUSSION SESSION
12:25-12:35	CLOSING WORDS	Dr. Daniel Garceau Dr. Louis-Denis Poulin
12:35-13:45	BUFFET LUNCH	Room 200

 

This program receives unrestricted educational grants from pharmaceutical companies Amgen Canada and Otsuka Canada without any regards to the choice of speakers, topics, choice of members of the scientific committee. We also offer our thanks to Amgen Canada as exhibitor.

 

OBJECTIVES

CONFERENCE 1

“ARTIFICIAL INTELLIGENCE IN NEPHROLOGY: FOR NOW, OR FOR LATER?”

SPEAKER

Dr. Wisit Cheungpasitporn, MD, FACP, FASN, FAST

Edit

TARGETED CANMEDS SKILLS:	☐ Medical Expert	☐ Communicator	☐ Collaborator	☒ Leader
	☐ Health Advocate	☒ Scholar	☐ Professional

 

LEARNING OBJECTIVES

1. To briefly discuss the concepts and the broad current usage of machine learning, artificial intelligence and natural language processing.
2. To discuss the potential usage of artificial intelligence in the field of clinical nephrology, using specifical examples, in relation to:
   1. diagnosis of diseases
   2. prediction of outcomes
   3. selection of treatments.
3. To explore the potential benefits and limitations of usage of artificial intelligence in this context.
4. To describe the usage of these tools in the next 5 to 10 years for healthcare providers involved in nephrology care.

CONFERENCE 2

“AUTOIMMUNE DISEASES, VASCULITIS AND PREGNANCY; HOW TO TRANSFORM A DREAM TO REALITY!”

SPEAKER

Prof. Angela Tincani, MD

Edit

TARGETED CANMEDS SKILLS:	☒ Medical Expert	☐ Communicator	☐ Collaborator	☐ Leader
	☐ Health Advocate	☒ Scholar	☐ Professional

 

LEARNING OBJECTIVES

Using clinical cases for a multidisciplinary audience (nephrologists, pharmacists, nurses, dietitians):

1. To discuss the impact of some current autoimmune diseases and vasculitis (lupus, ANCA vasculitis) on fertility for young women afflicted by these diseases.
2. To review the clinical management before and during pregnancy of these women, more specifically in relation to:
   1. usage of immunosuppressive drugs
   2. monitoring of diseases activity
   3. impact of these diseases on blood pressure control and kidney function
3. To recognize, prevent or manage specific complications related to these diseases during pregnancy, such as:
   1. thromboembolic disorders
   2. preeclampsia
   3. antiphospholipid syndrome
   4. flare-up of these diseases
4. To schematize the impact of these diseases and their therapeutics on lactation and future baby’s health.

CONFERENCE 3

“HIGHLIGHTS IN 2024 TO SHARE” (Lectures in French)

SPEAKERS

Ms. Isabelle Vaillant, M.Sc Inf. 
Ms. Jodianne Couture, B. Pharm., M.Sc  
Dr. Philippe Lachance, MD, M.Sc
Ms. Roxanne Papineau, Dt.P

LEARNING OBJECTIVES
To share with colleagues the vision of one member of each professional group involved, and more specifically:

1. To present relevant concepts (diagnostic, therapeutic, behavioural, organizational approaches or notions acquired in 2024) to the members of multidisciplinary teams in nephrology.
2. To illustrate how the concepts of interest acquired in 2024 can apply in a multidisciplinary practice for the different groups of healthcare professionals.
3. To integrate the concepts conveyed in the presentation to the current practice of the members of the healthcare teams.

CONFERENCE 4

“WATER AND SALT INTAKE WITH CKD; IS IT TOO MUCH OR NOT ENOUGH?” 

SPEAKER

Dr. Biff F. Palmer, MD 

LEARNING OBJECTIVES

Using clinical cases or vignettes in this conference for a multidisciplinary audience (pharmacists, nurses, dietitians, nephrologists)

1. To discuss the rationale of fluid and salt intake targets in the presence of CKD stage 3 to 5.
2. To describe clinical tools available in current practice to better define target weight and optimal fluid balance for this clientele, and to prevent overhydration or dehydration.
3. To explore in this context ways to correct or prevent hypo or hypernatremic states and to predict the need of water or salt intake.
4. To promote future usage of readily clinical tools to better advice stage 3 to 5 CKD patients on their daily fluid and salt intake.

CONFERENCE 5

“A KIDNEY GRAFT RECIPIENT; THE BEGINNING AND THE END OF THE STORY”

Edit

TARGETED CANMEDS SKILLS:	☒ Medical Expert	☐ Communicator	☐ Collaborator	☐ Leader
	☐ Health Advocate	☒ Scholar	☐ Professional

Part 1: “PREEMPTIVE KIDNEY GRAFT: A USER GUIDE” 

SPEAKER

Dr. Michelle A. Josephson, MD 

LEARNING OBJECTIVES

1. To demonstrate the benefits of pre-emptive kidney grafts over dialysis therapies for eligible CKD patients.
2. To describe selection and exclusion criteria to better define the CKD clientele eligible for pre-emptive kidney graft.
3. To discuss the potential benefits and hazards related to pre-emptive kidney graft, in relation to:
   1. age of the recipients
   2. residual value of eGFR
   3. etiologies of kidney failure
   4. other pertinent aspects

Part 2: “A KIDNEY GRAFT RECIPIENT; THE BEGINNING AND THE END OF THE STORY” 

SPEAKER

Dr. Michelle A. Josephson, MD 

LEARNING OBJECTIVES 

1. To briefly discuss the kidney graft survival time, and the major causes of a failing graft or major eGFR drop.
2. To propose strategies for clinicians involved in the care of these patients, in the model of pre-dialysis clinics in relation to:
   1. management of immunosuppressive drugs
   2. preservation on residual eGFR
   3. removal (or not) of the failing kidney graft
3. To analyze the benefits related to a new pre-emptive kidney transplantation versus the beginning of dialysis therapies.

CONFERENCE 6

“SHARED DECISION MAKING IN CKD; A PATIENT’S AND A CAREGIVER’S PERSPECTIVE”

Part 1: “SHARED DECISION MAKING: WHAT IS THE LITERATURE TELLING US IN 2024?” (Lecture in French)

SPEAKER

Dr. Patrick Archambault, MD, M.Sc, FRCPC

 LEARNING OBJECTIVES

1. To briefly define the concept of shared decision making in 2024.
2. To explore the challenges to achieve an adequate process of shared decision, in relation to the patient’s background knowledge of his disease:
   1. quality and clarity of explanations
   2. resolution of matters raised
   3. mixed messaging
   4. interaction with the patient’s family members and other caregivers
3. To provide helpful clues and tools to achieve better communication and shared decision process.
4. To demonstrate during the joint discussion period, with a moderator and a patient suffering from CKD, the potential usage of these tools.

(***Following this conference, a patient will discuss his personal experience of decision-making process, in relation to his status of CKD patient, in different aspects of his medical history: end-stage kidney failure, choice of dialysis modality, possibility of future kidney transplant).

Part 2: “SHARED DECISION MAKING: A PATIENT’S PERSPECTIVE.” (Lecture in French) 

SPEAKER

Mr. Réjean Lemoine 

LEARNING OBJECTIVES

1. To describe the journey of a CKD patient, from a personal perspective, from CKD stage 3 to 5 to dialysis, and eventually to a kidney transplant.
2. To demonstrate with specific and personal examples the impact of the decision-making process on:
   1. acceptance of his disease
   2. integration of his own values and priorities in the decision-making process
   3. emotions
3. To summarize some aspects to achieve a better quality of shared decision-making process.
4. To discuss during the joint session with the moderator and the first speaker ways to enhance in the future the quality of this process.

Organized in collaboration with the SQN

Saturday, October 5th, and Sunday, October 6th, 2024

Printable Version Click Here

---

Skills development in the CanMEDS roles targeted by this activity:

• Medical Expert
• Collaborator
• Leader
• Health Advocate
• Scholar
• Professional

 

Accreditation

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and a Recognized Professional Development Activity (Category A) as defined by the Collège des médecins du Québec. This activity was approved by the direction de Développement professionnel continu (DDPC) of the Fédération des médecins
spécialistes du Québec.

You may claim a maximum of 7.5 Accredited Group Learning Activity (Section 1) / Recognized Professional Development Activity (Category A) hours. Participants must claim a number of hours consistent with their attendance.

 

GENERAL LEARNING OBJECTIVES

1. To explore new useful diagnostic or therapeutic avenues in 2024.
2. To promote professional exchanges in discussion forums.
3. To address new cutting-edge scientific concepts, through interviews with national or international content experts.
4. To optimize the quality of healthcare to be provided to clients with nephrology-related clinical conditions.

***NOTE: F.E.N. 2024 is a full-day CME activity. Unlike the 22ND ANNUAL CONFERENCE OF “FONDATION D.E.V.E.N.I.R.”, participants will only be able to register and attend the entire educational program F.E.N.***

SCIENTIFIC PROGRAM – DAY 1 

***Note: NO SIMULTANEOUS TRANSLATION WILL BE AVAILABLE*** 

Saturday, October 5, 2024

This program receives unrestricted educational grant from pharmaceutical company Amgen Canada, without any regards to the choice of speakers, topics, choice of members of the scientific committee. We offer our thanks to Amgen Canada as exhibitor.

SCIENTIFIC PROGRAM – DAY 2

***Note: NO SIMULTANEOUS TRANSLATION WILL BE AVAILABLE*** 

Sunday, October 6, 2024

This program receives unrestricted educational grant from pharmaceutical company Amgen Canada, without any regards to the choice of speakers, topics, choice of members of the scientific committee. We offer our thanks to Amgen Canada as exhibitor.

 

OBJECTIVES

CONFERENCE 1

“LUPUS NEPHRITIS: WHAT’S NEW IN 2024?”

SPEAKER

Dr. Brad Rovin, MD, FASN, FACP 

TARGETED CANMEDS SKILLS:	☒ Medical Expert	☐ Communicator	☐ Collaborator	​​☐​ Leader
	☐ Health Advocate	​​☒​​ Scholar	​​☐​ Professional

LEARNING OBJECTIVES

1. To discuss the latest updates of KDIGO and EULAR guidelines regarding the management of lupus nephritis, in relation to induction and remission treatments.
2. To explore the benefits of usage of multiple different therapies (such as belimumab and voclosporin) to treat patients afflicted by lupus nephritis.
3. To schematize an algorithm of therapies and follow-up tests (blood tests, kidney biopsies) to optimize the management of these patients.
4. To suggest therapeutic approaches in the presence of refractory disease.

CONFERENCE 2

“CYSTIC KIDNEY DISEASES: WHAT ELSE OTHER THAN POLYCYSTIC KIDNEY DISEASE?”

SPEAKER

Dr. Johannes Münch, MD 

TARGETED CANMEDS SKILLS:	☒ Medical Expert	☐ Communicator	☐ Collaborator	​​☐​ Leader
	☐​ Health Advocate	​​☒​​ Scholar	​​☐​ Professional

LEARNING OBJECTIVES

Using clinical cases 

1. To explore the spectrum of ciliopathies and monogenic cystic renal diseases, notwithstanding polycystic kidney diseases.
2. To discuss the clinical presentation of some of these ciliopathies (nephronophthisis, Bardet-Biedl syndrome, Joubert syndrome, ciliopathies with extra-renal manifestations), ARPKD, Meckel-Gruber syndrome, tuberous sclerosis complex, or other diseases.
3. To integrate usage of genetic testing, if appropriate, to optimize the diagnosis and the management of these diseases.
4. To propose useful clinical tools to help healthcare professionals to detect and diagnose these diseases.

CONFERENCE 3

“RESISTANT HYPERTENSION: WHAT WE SHOULD KNOW AND DO NEXT AS NEPHROLOGISTS?”

SPEAKER

Dr. Debbie L. Cohen, MD    

TARGETED CANMEDS SKILLS:	☒ Medical Expert	☐ Communicator	☐ Collaborator	​​☐​ Leader
	☒​ Health Advocate	​​☒​​ Scholar	​​☐​ Professional

LEARNING OBJECTIVES

1. To recognize the problem of resistant hypertension, to discuss its major etiologies and its prevalence in reference centers.
2. To explore methods to better assess patients suffering from resistant hypertension, and to integrate useful diagnostic tools to better manage these patients.
3. To debate the benefits and limitations of renal denervation in this context.
4. To schematize useful diagnostic and therapeutic approaches for nephrologists involved in the care of these patients.

CONFERENCE 4

“FOCAL SEGMENTAL GLOMERULOSCLEROSIS: SHADOWS AND LIGHT”

SPEAKER

Dr. Sanjeev Sethi, MD, PhD 

TARGETED CANMEDS SKILLS:	☒ Medical Expert	☐ Communicator	☐ Collaborator	​​☐​ Leader
	☐ Health Advocate	☒​​ Scholar	​​☒​​​ Professional

LEARNING OBJECTIVES

1. To briefly review the prevalence, etiologies and classification of focal segmental glomerulosclerosis.
2. To explore mechanisms explaining the occurrence of this disease.
3. To discuss the benefits and limitations of usage of genetic testing in the presence of this disease, for adult patients.
4. To recommend useful therapeutic strategies to treat this disease, and debate their benefits and limitations.
5. To propose an investigation and therapeutic plan useful in the process of kidney graft, for patients suffering from end-stage kidney failure related to focal segmental glomerulosclerosis.

CONFERENCE 5

“MANAGEMENT OF HYPONATREMIA: MYTHS AND REALITIES”

SPEAKER

Dr. Biff F. Palmer, MD 

TARGETED CANMEDS SKILLS:	☒ Medical Expert	☐ Communicator	☐ Collaborator	​​☒​ Leader
	☒​ Health Advocate	☒​​ Scholar	​​☐​ Professional

LEARNING OBJECTIVES

Using clinical cases

1. To briefly review the regulation of body tonicity and the mechanisms explaining the occurrence of hyponatremia.
2. To define hyponatremia, its classification and discuss its etiologies.
3. To integrate in daily clinical practice an algorithm of investigation and approaches of hyponatremia.
4. To explore strategies to correct hyponatremia in different clinical situations, and to prevent complications related to its occurrence or to its overcorrection.
5. To propose helpful clinical tools to healthcare professionals in this context.

CONFERENCE 6

“FLUID MANAGEMENT IN THE INTENSIVE CARE UNIT: TOO MUCH, TOO LITTLE, OR JUST ENOUGH?” (Lecture in French) 

SPEAKER

Dr. William Beaubien-Souligny, MD, PhD

TARGETED CANMEDS SKILLS:	☒ Medical Expert	☐ Communicator	☒​ Collaborator	​​☒​ Leader
	​​☒​ Health Advocate	​​☒​​ Scholar	​​☐​ Professional

LEARNING OBJECTIVES

1. To briefly review the consequences of hypovolemia and hypervolemia for patients staying in intensive care units.
2. To explore techniques, tools, biomarkers to assess adequately fluid needs and body fluid status of these patients, such as
   

   ultrasound pulse pressure variation

   oxygen saturation bioimpedance

   some biomarkers other useful tools

3. To discuss the impact of usage of different types of available fluids on outcomes of patients staying in intensive care unit.
4. To propose an algorithm based on useful tools and techniques to better manage these patients in the future.